Though this effect on AUC did not reach statistical significance due to the wide interpatient variability in RAL PK, these increases are greater than previously observed in healthy volunteers (4 and 11%, respectively) [ 15 ].
← all excerpts
Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s.
1
—
—